Health Alerts

Date Issued
Title
11/16/2016
Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) by St. Jude Medical: FDA Safety Communication - Batteries May Fail Earlier Than Expected (10-11-2016)
11/16/2016
Vascular Solutions, Inc. Issues Recall of Twin-Pass® Dual Access Catheters (10/4/2016)
11/16/2016
Nurse Assist Initiates Nationwide Voluntary Recall of All Unexpired Lots of I.V. Flush Syringes (10-4-2016)
11/16/2016
Direct-Acting Antivirals for Hepatitis C: Drug Safety Communication - Risk of Hepatitis B Reactivating (10-4-2016)
11/16/2016
50mm 0.2 Micron Filters by Baxter: Recall - Potential for Missing Filter Support Membrane, Particulate Matter (10/3/2016)
10/17/2016
Trividia Health (formerly Nipro Diagnostics) announced a voluntary recall of certain lots of TRUEread, TRUEbalance, TRUEtrack, and TRUEtest blood glucose test strips after determining that some may include open test strip vials within the sealed vial boxes
10/17/2016
Novel Laboratories Recalls Zolpidem Tartrate Blister Packs Due to Failure to Meet Child-Resistant Closure Requirement; Risk of Poisoning
10/17/2016
Recall of scopalamine in response to increased reports of damaged product that may alter the predicted release during transdermal application
9/20/2016
On May 6, 2016, Abbott Nutrition recalled one lot (57648RA11, expiring Jan. 1, 2017) of Nepro® with Carb Steady Therapeutic Nutrition, Vanilla, in 8-ounce metal cans (NDC# 70074-0620-95). The contents of some cans have a different color, smell, taste or texture than product from other lots. For more information about the recall please contact Abbott Customer Service at 800.986.8724
9/20/2016
0.25 Percent Bupivacaine Hydrochloride Injection, USP by Hospira: Recall - Particulate Matter
9/20/2016
Dexcom Inc. Recalls G4 Platinum and G5 Mobile Continuous Glucose Monitoring System Receivers Due to Audible Alarm Failure
9/20/2016
FDA issues final rule on safety and effectiveness of antibacterial soaps
9/20/2016
Fluoroquinolone Antibacterial Drugs for Systemic Use: Drug Safety Communication - Warnings Updated Due to Disabling Side Effects
9/20/2016
Hyoscyamine sulfate 0.125mg by Virtus Pharmaceuticals: Recall - Superpotent and Subpotent Test Results
9/20/2016
Lamotrigine Orally Disintegrating Tablet 200 mg by Impax: Recall - Incorrect Labeling of Blister Cards
9/20/2016
Liquid Drug and Dietary Supplement Products by PharmaTech: Recall - Risk of Product Contamination
9/20/2016
Norditropin FlexPro devices may become blocked during the “air-shot” that expels air from the cartridge before use. An under-dose or no dose of Norditropin may result (5-29-2016)
9/20/2016
Novo Nordisk Inc. issues voluntary nationwide recall of six batches of GlucaGen® HypoKit® (glucagon [rDNA origin] for injection) due to detached needles on the syringe in the kit
9/20/2016
Opioid Pain or Cough Medicines Combined With Benzodiazepines: Drug Safety Communication - FDA Requiring Boxed Warning About Serious Risks and Death
9/20/2016
Programmable Syringe Pumps: FDA Safety Communication - Problems With Fluid Flow Continuity at Low Infusion Rates
9/20/2016
Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Oxacillin for Injection, USP, 10g Due to Presence of Iron Oxide Particulate Matter
9/20/2016
Talon Compounding Pharmacy Issues Voluntary Nationwide Recall of HCG and Sermorelin Due to Lack of Sterility Assurance
9/20/2016
United Exchange Corp. Issues Voluntary Nationwide Recall of Eye Wash/Eye Irrigating Solutions Distributed by Major Pharmaceuticals and Rugby Laboratories Due to Microbial Contamination
9/20/2016
Voluntary Nationwide Recall of Cetylev® (Acetylcysteine) Effervescent Tablets for Oral Solution Due to an Inadequate Seal of the Blister Pack
7/19/2016
FDA approves a dedicated syringe to be used with Humulin R U-500 insulin - Drug Information Update
7/19/2016
Oral Liquid Docusate Sodium by PharmaTech: Recall - Contaminated with B. Cepacia
6/22/2016
Aripiprazole (Abilify, Abilify Maintena, Aristada): Drug Safety Communication - FDA Warns About New Impulse-control Problems
6/22/2016
BiCNU (carmustine for injection): FDA Alert - Counterfeit Product Discovered in Some Foreign Countries
6/22/2016
Brintellix (vortioxetine): Drug Safety Communication - Brand Name Change to Trintellix, to Avoid Confusion With Antiplatelet Drug Brilinta (ticagrelor)
6/22/2016
Canagliflozin (Invokana, Invokamet) and Dapagliflozin (Farxiga, Xigduo XR): Drug Safety Communication - Strengthened Kidney Warnings
6/22/2016
Diabetes Medications Containing Saxagliptin and Alogliptin: Drug Safety Communication - Risk of Heart Failure
6/22/2016
FDA Drug Safety Communication: Interim clinical trial results find increased risk of leg and foot amputations, mostly affecting the toes, with the diabetes medicine canagliflozin (Invokana, Invokamet); FDA to investigate
6/22/2016
FDA Drug Safety Communication: FDA evaluating the risk of burns and scars with Zecuity (sumatriptan) migraine patch
6/22/2016
FDA Drug Safety Communication: FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse
6/22/2016
Fluconazole (Diflucan): Drug Safety Communication - FDA Evaluating Study Examining Use of Oral Fluconazole (Diflucan) in Pregnancy
6/22/2016
Fluoroquinolone Antibacterial Drugs: Drug Safety Communication - FDA Advises Restricting Use for Certain Uncomplicated Infections
6/22/2016
Hospira Issues A Voluntary Recall For One Lot Of 50% Magnesium Sulfate Injection, USP Due To The Presence Of Particulate
6/22/2016
Nizoral (ketoconazole) Oral Tablets: Drug Safety Communication - Prescribing for Unapproved Uses including Skin and Nail Infections Continues; Linked to Patient Death
6/22/2016
Olanzapine: Drug Safety Communication - FDA Warns About Rare But Serious Skin Reactions
6/22/2016
Over-the-Counter Antacid Products Containing Aspirin: FDA Drug Safety Communication - Serious Bleeding Risk
6/22/2016
PharMEDium Issues Voluntary Nationwide Recall Sterile Preparations Compounded With a Single Recalled Lot of Fresenius Kabi Sensorcaine-MPF (bupivacaine HCl) Due to the Presence of Glass Particulate Matter
6/22/2016
Sensorcaine-MPF (bupivacaine HCl) by Fresenius Kabi: Recall - Presence of Particulate Matter
6/22/2016
Sterile Drug Products from Pharmakon Pharmaceuticals: Recall - Lack of Sterility Assurance
6/22/2016
Well Care Compounding Pharmacy Issues Voluntary Statewide Recall of All Sterile Compounded Products Due to Lack Of Assurance if Sterility Concerns
6/22/2016
Zecuity manufacturer Teva Pharmaceuticals has decided to temporarily suspend sales, marketing, and distribution to investigate the cause of burns and scars associated with the Zecuity patch.
4/18/2016
FDA takes important step to increase the development of, and access to, abuse-deterrent opioids
4/18/2016
Amikacin Sulfate Injection USP, 1 gram/4mL (250 mg/mL) Vials by Teva: Recall - Glass Particulate Matter
4/18/2016
FDA warns consumers about potential risks of using eye drops packaged in bottles with loose safety seals
4/18/2016
Hospira Issues a Voluntary Recall for One Lot of Sodium Bicarbonate Injection, USP Due to the Presence of a Particulate
4/18/2016
FDA announces enhanced warnings for immediate-release opioid pain medications related to risks of misuse, abuse, addiction, overdose and death
4/18/2016
"Reliable Drug" Recalls All Compounded Medications Due to a Potential for Mislabeling and Lack of Quality Assurance
4/18/2016
FDA Alerts Healthcare Professionals About Clinical Trials with Zydelig (idelalisib) in Combination with other Cancer Medicines
3/7/2016
Fluconazole Injection, USP, (in 0.9 Percent Sodium Chloride) 200mg per 100ml: Recall - Elevated Impurity
3/7/2016
Morphine Sulfate 0.5 mg/mL Preservative Free in 0.9 percent Sodium Chloride by Pharmakon Pharmaceuticals: Recall - Super-potent Product
3/7/2016
Baxter Issues Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Solution for Irrigation Due to Presence of Particulate Matter
2/1/2016
Baxter Initiates Voluntary Recall of Two Lots of IV Solutions due to Potential Presence of Particulate Matter
2/1/2016
Baxter IV Solutions (Select Lots): Recall - Potential for Leaking Containers and Particulate Matter
2/1/2016
Licorice Coughing Liquid OTC Cough Syrup by Ma Ying Long Pharmaceutical Group: CDER Alert - Contains Unidentified Morphine
2/1/2016
Magnesium Sulfate in Water for Injection by Hospira: Recall - Incorrect Barcode Labeling on the Primary Container
2/1/2016
Master Herbs, Inc. Issues Voluntary Nationwide Recall of All Lots of Licorice Coughing Liquid Due to the Presence of Morphine
2/1/2016
FDA Drug Safety Communication: FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved
2/1/2016
Perrigo Initiates Voluntary Product Recall in the U.S. Of Children's Guaifenesin Grape Liquid and Guaifenesin DM Cherry Liquid Due to a Potential Defect with the Dosage Cup
2/1/2016
Unexpired Sterile Human and Animal Compounded Products by Abbott's Compounding Pharmacy: Recall - Lack of Sterility Assurance
1/1/2016
Pharmedium Issues Voluntary Nationwide Recall of 4mg Norepinephrine Bitartrate (16mcg/mL) Added to 0.9% Sodium Chloride in 250mL Viaflex Bag and 8mg Norepinephrine Bitartrate (32mcg/mL) Added to 0.9% Sodium Chloride in 250mL Viaflex Bag for Discoloration
12/29/2015
Rosiglitazone-containing Diabetes Medicines: Drug Safety Communication - FDA Eliminates the Risk Evaluation and Mitigation Strategy (REMS)
12/15/2015
Baclofen Active Pharmaceutical Ingredient from Taizhou Xinyou Pharmaceutical and Chemical: FDA Statement - FDA Warns of Potential Contamination
12/15/2015
FDA working with manufacturers to resolve challenges with the Clozapine REMS Program
12/15/2015
FDA Drug Safety Communication: FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections
12/15/2015
FDA takes action to protect consumers from potentially dangerous dietary supplements
12/15/2015
Insulet Corporation Issues Field Safety Notification of OmniPod Insulin Management System
12/15/2015
FDA Drug Safety Podcast: FDA review finds long-term treatment with blood-thinning medicine Plavix (clopidogrel) does not change risk of death
12/15/2015
FDA Announces Glades Drugs' Nationwide Voluntary Recall Of Compounded Multivitamins Containing High Amounts Of Vitamin D3 (Cholecalciferol)
12/15/2015
FDA Drug Safety Communication: FDA advises of rare cases of underactive thyroid in infants given iodine-containing contrast agents for medical imaging
11/12/2015
Acetaminophen Tablets by Medline Industries: Recall - Mislabeling with Incorrect Strength
11/12/2015
Plavix (clopidogrel): Drug Safety Communication - Long-term Treatment Does Not Change Risk of Death
11/12/2015
Entacapone: Drug Safety Communication - FDA Review Found No Increased Cardiovascular Risks
11/12/2015
Auvi-Q (epinephrine injection, USP): Recall - Potential Inaccurate Dosage Delivery
11/12/2015
Kayexalate (sodium polystyrene sulfonate): Drug Safety Communication - FDA Requires Drug Interaction Studies
11/12/2015
FDA alerts health care professionals not to use sterile drug products from Qualgen
11/12/2015
Hepatitis C Treatments Viekira Pak and Technivie: Drug Safety Communication - Risk of Serious Liver Injury
10/14/2015
Avycaz (ceftazidime and avibactam): Drug Safety Communication - Dose Confusion and Medication Errors
10/14/2015
Clozapine: Drug Safety Communication - FDA Modifies Monitoring for Neutropenia; Approves New Shared REMS Program
10/14/2015
FDA Drug Safety Communication: FDA warns that DPP-4 inhibitors for type 2 diabetes may cause severe joint pain
10/14/2015
Invokana and Invokamet (canagliflozin): Drug Safety Communication - New Information on Bone Fracture Risk and Decreased Bone Mineral Density
10/14/2015
Refresh Lacri-Lube, Refresh P.M., FML 0.1 Percent and Blephamide 10 Percent/0.2 Percent by Allergan: Recall - Particulate Matter
10/14/2015
Medistat RX Sterile Drug Products: Recall - Possible Contamination
10/14/2015
US Compounding, Inc. Issues Voluntary Nationwide Recall of All Sterile Compounded Products
10/14/2015
FDA Drug Safety Communication: FDA evaluating the risks of using the pain medicine tramadol in children aged 17 and younger
10/9/2015
Adrucil (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) by Teva Parenteral Medicines: Recall - Particulate Matter
10/9/2015
Compounded Drugs Stored in Becton-Dickinson (BD) 3 ml and 5 ml Syringes: FDA Warning - Do Not Use
10/9/2015
Brintellix (vortioxetine) and Brilinta (ticagrelor): Drug Safety Communication - Name Confusion
10/9/2015
Hydrochlorothiazide Tablets by Unichem Pharmaceuticals (USA), Inc: Recall - Potential Presence of Foreign Tablets Contamination
10/9/2015
Picato (ingenol mebutate) Gel: Drug Safety Communication - FDA Warns of Severe Adverse Events, Requires Label Changes
10/9/2015
0.9 Percent Sodium Chloride Injection, USP (AUTO-C) by Baxter International: Recall - Potential For Leaking Containers, Particulate Matter and Missing Port
7/21/2015
0.9 Percent Sodium Chloride Injection, USP, 50mL and 100mL by Baxter: Recall - Particulate Matter
7/16/2015
Codeine Cough-and-Cold Medicines in Children: Drug Safety Communication - FDA Evaluating Potential Risk of Serious Side Effects
7/16/2015
Non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Drug Safety Communication - FDA Strengthens Warning of Increased Chance of Heart Attack or Stroke
7/16/2015
Proglycem (diazoxide): Drug Safety Communication - Reports of Pulmonary Hypertension in Infants and Newborns
7/15/2015
Calcium Chloride Intravenous Infusion 10% w/v 10mL Prefilled Syringe by Mylan: Market Withdrawal - Difficulties in Administration
7/8/2015
FDA warns consumers who purchase Diazepam online of potentially serious counterfeiting issue
7/8/2015
Unapproved Prescription Ear Drop (Otic) Products: Not FDA Evaluated for Safety, Effectiveness and Quality
6/29/2015
Daytrana Patch (methylphenidate transdermal system): Drug Safety Communication - Permanent Skin Color Changes
6/17/2015
Potiga (ezogabine): Drug Safety Communication - FDA Determines 2013 Labeling Adequate to Manage Risks of Retinal Abnormalities, Potential Vision Loss, and Skin Discoloration
6/11/2015
Mylan is Expanding its Voluntary Nationwide Recall of Select Lots of Injectable Products Due to the Presence of Particulate Matter
6/2/2015
FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood
5/22/2015
Zerbaxa (ceftolozane and tazobactam): Drug Safety Communication - FDA Cautions About Dose Confusion and Medication Errors
5/6/2015
Intravenous (IV) Solutions (Select Lots) by Baxter: Recall - Potential Presence of Particulate Matter
5/6/2015
Flurbiprofen-Containing Topical Pain Medications: FDA Alert - Illnesses and Deaths in Pets Exposed to Prescription Topical Pain Medication
5/6/2015
Mucinex Fast-MAX Products: Recall - Incorrect Labeling
5/6/2015
Injectable Products by Mylan: Recall - Presence of Particulate Matter
5/6/2015
Bupivacaine HCl Injection by Hospira: Recall - Iron Oxide Particulate In Glass Vials
5/6/2015
Adrucil (fluorouracil Injection, USP) 5 g/100 mL (50 mg/mL): Recall - Particulate Matter
4/1/2015
0.9 Percent Sodium Chloride Injection, USP, 250 mL VisIV Container by Hospira: Recall - Particulate Matter
4/1/2015
FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol)
4/1/2015
FDA Drug Safety Communication: FDA warns of serious slowing of the heart rate when antiarrhythmic drug amiodarone is used with hepatitis C treatments containing sofosbuvir Harvoni or Sovaldi in combination with another Direct Acting Antiviral drug
4/1/2015
FDA Drug Safety Communication: FDA review of study sheds light on two deaths associated with the injectable schizophrenia drug Zyprexa Relprevv (olanzapine pamoate)
4/1/2015
FDA warns consumers about the potential health risks of over-the-counter asthma products labeled as homeopathic
4/1/2015
Hospira Issues a Voluntary Nationwide Recall of One Lot of Lactated Ringer's Irrigation Due to Mold Contamination
4/1/2015
Chantix (varenicline): Drug Safety Communication - FDA Updates Label to Include Potential Alcohol Interaction
4/1/2015
Hospira Issues a Voluntary Nationwide Recall of One Lot of Magnesium Sulfate in 5% Dextrose Injection Due to Incorrect Barcode Labeling
3/5/2015
Atracurium Besylate Injection by Sagent Pharmaceuticals: Recall - Potential Impact on Product Sterility
3/5/2015
Testosterone Products: - FDA Cautions About Using Testosterone Products for Low Testosterone Due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack And Stroke
3/4/2015
Colistimethate for Injection USP, 150 mg and Rifampin for Injection USP, 600 mg/vial by Heritage Pharmaceuticals: Recall - Lack of Sterility Assurance
3/2/2015
Tuberculosis Outbreak in Sunset Park, Brooklyn
2/13/2015
Ketorolac Tromethamine Injection by Hospira: Recall - Particulate in Glass Vials
2/4/2015
Quick Guide to When to Prescribe a Flu Antiviral
2/3/2015
Antiviral Treatment for Influenza Infection
1/28/2015
Hospira Issues a Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Injection, USP, Due to Particulate Matter
1/28/2015
CDC Advisory: Multistate Measles Outbreak
1/20/2015
Virazole (Ribavirin Powder For Solution) (Valeant pharmaceuticals): Recall- Microbial Contamination
1/14/2015
CDC: Update on Treatment of Influenza With Antiviral Medications
1/13/2015
Emergency Post-Exposure Prophylaxis Can Prevent HIV Infection
1/13/2015
NYC DOHMH: Influenza Advisory
1/12/2015
Practi-0.9% Sodium Chloride IV bags & Practi-0.9% Sodium Chloride IV bags filled with sterile distilled water
1/9/2015
Prescription and Over-the-Counter (OTC) Pain Medicines: Drug Safety Communication - FDA Review of Possible Risks of Pain Medicine Use During Pregnancy
1/8/2015
Fourth case of neonatal herpes infection after ritual Jewishcircumcision in NYC in 2014
1/6/2015
0.9 Percent Sodium Chloride Injection USP mini bag Container by Baxter: Recall - Particulate Matter
1/6/2015
Ziprasidone (Geodon and Generics): Drug Safety Communication - Rare But Potentially Fatal Skin Reaction
1/6/2015
Tecfidera (dimethyl fumarate) by Biogen Idec: Drug Safety Communication - Case of Rare Brain Infection PML Reported
1/6/2015
Gabapentin Capsules, USP 300 mg, by Aurobindo Pharma USA: Recall - Empty Capsules
1/6/2015
Highly Concentrated Potassium Chloride Injection by Baxter: Recall - Mislabeled Overpouch
1/6/2015
Intravia Containers by Baxter: Recall - Particulate Matter
1/6/2015
Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose, Preservative-Free, by Hospira: Recall - Particulate Matter
1/6/2015
Assured Brand Naproxen Sodium Tablets by Contract Packaging Resources, Inc.: Recall - Packaging Mix-Up
1/6/2015
Vancomycin Hydrochloride for Injection US Recall - Uncontrolled Storage During Transit
1/6/2015
Ketorolac Tromethamine Injection Recall - Incorrect Labeling
12/19/2014
Outbreak of Shigellosis in Borough Park and Williamsburg
12/4/2014
CDC: Potential for Circulation of Drifted Influenza A (H3N2) Viruses
10/23/2014
NYC DOHMH: First Presumed Case of Ebola in NYC
10/23/2014
For steps to take with potential patients, please use the Ebola Virus Disease Evaluation Algorithm from the NYCDOHMH
10/16/2014
New York State Ebola Preparedness Plan Designates Eight Hospitals to Provide Care
10/2/2014
NYC DOHMH: Assess Fall Risk Annually in Patients Age 65 and Older
9/30/2014
CDC: Acute Neurologic Illness With Focal Limb Weakness of Unknown Etiology in Children
9/23/2014
City Health Information: Diagnosing and Managing Hepatitis C
9/19/2014
CDC: Severe Respiratory Illness Associated With Enterovirus D68
9/19/2014
Enterovirus D-68 Infections in Children in NYC
9/12/2014
Cubist Pharmaceuticals Issues Voluntary U.S. Recall Of CertainLots Of CUBICIN
9/12/2014
NYC DOHMH: Update on Ebola Virus Outbreak in West Africa
9/12/2014
Five Human Cases of West Nile Virus Identified in NYC in 2014
9/12/2014
Three New Cases of Invasive Meningococcal Disease in NYC
9/8/2014
Amgen Issues Voluntary Recall of Aranesp®
8/14/2014
Ebola Virus Disease (EVD) Evaluation Algorithm
8/14/2014
Interim NYS/NYC Guidelines for Handling Ebola Virus Disease Specimens
8/14/2014
Evaluating Patients for Ebola Virus Disease in New York City
8/11/2014
CDC: Confirmed Cases of Ebola Virus Disease in Nigeria and Liberia
8/11/2014
CDC: Guidelines for Evaluation of Suspected Ebola Virus in US Patients
7/31/2014
NYC DOHMH: Increase in Adverse Events Associated With Synthetic Cannabinoids
7/31/2014
NYC DOHMH: Pesticide Spraying in Queens to Reduce Mosquito Activity
7/23/2014
NYC DOHMH: West Nile Virus
7/23/2014
NYC DOHMH: New Cases of Neonatal Herpes Following Jewish Ritual Circumcision
7/23/2014
NYC DOHMH: Invasive Meningococcal Disease in Men Who Have Sex With Men
7/21/2014
Bayer Recalls Solutions
6/30/2014
Lidocaine Viscous: Drug Safety Communication - Boxed Warning Required - Should Not Be Used to Treat Teething Pain
6/30/2014
Over The Counter Topical Acne Products Drug Safety CommunicationOver-The-Counter Topical Acne Products: Drug Safety Communication - Rare But Serious Hypersensitivity Reactions
6/9/2014
New WHO Polio Vaccination Requirements for Travelers
5/20/2014
NYC DOHMH Reminder: Spring Tree Pollen Can Exacerbate Asthma in Some Patients
5/20/2014
NYC DOHMH: Take a Travel History for Patients Hospitalized With Severe Acute Respiratory Illness
5/19/2014
CDC: Confirmed Case of MERS-CoV in Indiana
5/16/2014
Wockhardt Recalls over 109,000 Bottles of Hypertension Drug in U.S.(METOPROLOL)
5/16/2014
Dobutamine Injection (250mg/20mL)/Hospira: Recall - Visible Particulates
5/16/2014
Eszopiclone Containing Sleep Aids: Drug Safety Communication - Can Cause Next-Day Impairment Including Lunesta and generics
5/5/2014
All manufacturers of prescription combination drug products with more than 325 mg of acetaminophen have discontinued marketing
4/7/2014
NYC DOHMH Measles Outbreak FAQ
4/7/2014
NYC DOHMH Measles Outbreak FAQ - Spanish version
4/2/2014
NYC DOHMH Measles Update: Number of Cases Rises to 25
3/31/2014
Revatio (sildenafil): Drug Safety Communication - FDA Clarifies Warning About Pediatric Use for Pulmonary Arterial Hypertension
3/18/2014
NYC REACH Updates and Events
3/11/2014
Effexor XR 150 Mg ER Caps/ generic (Greenstone): Recall - Possible Tikosyn Capsules
3/10/2014
NYC DOHMH: Measles Cases Rise to 16 in NYC
3/6/2014
NYC DOHMH: Mumps in NYC
3/6/2014
NYC DOHMH: Mycobacterium Outbreak From Handling Raw Fish
2/26/2014
NYC DOHMH: Six Cases of Measles in NYC
2/10/2014
NYC DOHMH Advisory: Fentanyl-Associated Overdoses
1/31/2014
Alert #2 – New case of neonatal herpes infection following ritual Jewish circumcision
1/22/2014
Acetaminophen Prescription Combination Drug Products with more than 325 mg: FDA Statement - Recommendation to Discontinue Prescribing and Dispensing
1/22/2014
January 25: Get a Free Flu Vaccine in Brooklyn
1/17/2014
NYC REACH: Upcoming Health IT Events
1/17/2014
CDC First Confirmed Human Case of H5N1 Virus in North America
1/10/2014
Sodium Phosphate Over-the-Counter Products: Drug Safety Communication - Possible Harm From Exceeding Recommended Dose
1/10/2014
New PegIntron Selectdose single-use, dual-chamber pre-filled pen injector
1/10/2014
FDA Hepatitis Update - Changes to the Baraclude (entecavir) package and label
1/8/2014
NYC DOHMH: Influenza Advisory
1/3/2014
CDC: Early Reports of pH1N1-Associated Illnesses
12/17/2013
CDC Advisory - Recognizing, Managing, and Reporting Chikungunya Virus Infections in Travelers Returning from the Caribbean
12/10/2013
NYC Dept. of Health and Mental Hygiene: Preventing Sexually Transmitted Infections.
12/4/2013
Onfi (clobazam): Drug Safety Communication - Risk of Serious Skin Reactions
12/3/2013
Prolonged Meningococcal Disease Outbreak at Princeton
11/11/2013
2013-2014 Influenza Prevention and Control
11/8/2013
New Guidelines on Early Detection of Alzheimer’s Disease
10/18/2013
DOHMH: Severe Acute Respiratory Illness in Returning Travelers
10/17/2013
Nephron Pharmaceuticals Corporation Announces Voluntary Recall of Albuterol Sulfate Inhalation Solution, 0.083%
10/15/2013
CDC Weight Loss Dietary Supplement Linked to Liver Failure
10/11/2013
Inclusig (Ponatinib): Drug Safety Communication
9/26/2013
Arzerra and Rituxan - New Boxed Warnings
9/23/2013
Duragesic (fentanyl) Patches: Drug Safety Communication - Packaging Changes to Minimize Risk of Accidental Exposure
9/23/2013
NYC DOHMH Alert # 36 – Potential Exposure to Hepatitis A
9/9/2013
Cubicin (daptomycin for injection): Recall - Glass Particulate Matter Present in Four Lots
8/30/2013
Gilenya (fingolimod) - Drug Safety Communication: Investigating Rare Brain Infection
8/27/2013
DOHMH Alert # 33 - Possible Exposure to Hepatitis A
8/19/2013
Fluoroquinolone Antibacterial Drugs: Drug Safety Communication- Risk for possibly permanent nerve damage
8/15/2013
CDC Nationwide Voluntary Recall of All Sterile Products From Compounding Pharmacy in Cedar Park TX
8/15/2013
DOHMH Alert 31 Update on Invasive Meningococcal Disease in Men Who Have Sex With Men
8/14/2013
CDC: Updated Guidelines on Evaluation of Severe Respiratory Illness Associated With MERS-CoV
8/6/2013
2013 HEALTH ADVISORY #29: Pesticide Spraying Notification to Reduce Mosquito Activity and Control West Nile Virus in Queens & Staten Island
8/5/2013
2013 HEALTH ADVISORY #28: Pesticide Spraying Notification to Reduce Mosquito Activity and Control West Nile Virus in Queens
8/5/2013
DOHMH Alert #27: Nationwide Outbreak of Cyclosporiasis
8/5/2013
Mefloquine Hydrochloride: Drug Safety Communication - Label Changes Due To Risk of Serious Psychiatric and Nerve Side Effects
8/2/2013
Acetaminophen: Drug Safety Communication - Association with Risk of Serious Skin Reactions
7/30/2013
DOHMH Advisory #26: Pesticide Spraying Notification To Reduce Mosquito Activity and Control West Nile Virus in Queens
7/26/2013
DOHMH Advisory #25: Tularemia Advisory
7/26/2013
Nizoral (ketoconazole): Drug Safety Communication - Potentially Fatal Liver Injury, Risk of Drug Interactions and Adrenal Gland Problems
7/24/2013
DOHMH Alert #23: Update on Measles in New York City
7/16/2013
DOHMH Advisory #21: Tick-Borne Disease Advisory
7/10/2013
DOHMH Advisory #17: West Nile Virus
7/10/2013
DOHMH Alert #20: Heat Health Advisory
7/9/2013
DOHMH Alert #19: Increase in Reported Legionellosis Cases
7/8/2013
CDC Health Advisory: Variant Influenza Virus (H3N2v) Infections
7/3/2013
DOHMH Alert 18 Updated Telephone Number for Diseases That Must Be Reported Immediately
7/3/2013
Olmesartan Medoxomil: Drug Safety Communication - Label Changes To Include Intestinal Problems (Sprue-Like Enteropathy)
6/26/2013
CDC Health Advisory: Recommendations for Laboratory Testing for Acetyl Fentanyl and Patient Evaluation and Treatment for Overdose with Synthetic Opioids
6/25/2013
DOHMH Alert #16: Extreme Heat Health Advisory
6/17/2013
CDC Health Advisory: Nationwide Shortage of Doxycycline - Resources for Providers and Recommendations for Patient Care
6/12/2013
CDC: Updated Guidelines on Evaluation of Severe Respiratory Illness Associated With MERS-CoV
6/5/2013
DOHMH Alert #15: Update on Measles in NYC - New Vaccine Recommendations
5/31/2013
DOHMH Alert #14: Ricin-Contaminated Letter Sent to City Hall Mail Facility
5/29/2013
DOHMH Alert #13: Severe Acute Respiratory Illness in Returning Travelers
5/23/2013
DOHMH Alert #12: Update on Measles in New York City
5/21/2013
Methotrexate Sodium, USP Injectable Vials by Sandoz US: Recall - Particulate Matter In Vials
5/20/2013
Abbott Diabetes Care: Class 1 Recall - FreeStyle InsuLinx Blood Glucose Meters - Risk of Incorrect Test Result
5/7/2013
DOH Sign Up to Receive New and Improved Electronic Version of City Health Information
5/7/2013
Eba Multivitamin Supplement By Saratoga Therapeutics LLC: Recall - Allergy Alert On Undeclared Milk Components
5/7/2013
Kadcyla (ado-trastuzumab emtansine): Drug Safety Communication - Potential Medication Errors Resulting from Name Confusion
5/7/2013
Piperacillin and Tazobactam for Injection, USP 40.5 grams: Recall - Precipitation or Crystallization in IV Bag or IV Line Upon Reconstitution
5/7/2013
Sodium Chloride Injection 0.9 percent USP, 100 mL Flexible Containers by Hospira: Recall - Particulate Matter
5/7/2013
Valproate Anti-Seizure Products: Drug Safety Communication - Contraindicated for Pregnant Women for Prevention of Migraine Headaches
4/29/2013
Potiga (Ezogabine): Drug Safety Communication - Linked To Retinal Abnormalities And Blue Skin Discoloration
4/24/2013
LifeScan, Inc. OneTouch Verio IQ Blood Glucose Meter - Class I Recall: Failure to Provide a Warning at Extremely High Blood Glucose Levels
4/17/2013
FDA approves abuse-deterrent labeling for reformulated OxyContin. Agency will not approve generics to original OxyContin
4/16/2013
URGENT PRODUCT RECALL -FreeStyle InsuLinx Blood Glucose Meter
4/16/2013
DOHMH Alert #9: Measles in New York City
4/16/2013
Medicines in My Home Update: Safe Disposal of Fentanyl Transdermal System “Patches”
4/11/2013
Important information for patients: Voluntary recall of LEVOXYL
4/9/2013
DOHMH Alert #8: Update: Exposure to Hepatitis A in Patrons of Alta Restaurant
4/9/2013
DOHMH Alert #7: Update: Neonatal Herpes Infection Following Ritual Jewish Circumcision
3/20/2013
Avastin Unit Dose Syringes by Clinical Specialties: Recall - Potential For Serious Eye Infection
3/19/2013
Medication Safety link on Acetaminophen for your patients
3/18/2013
Incretin Mimetic Drugs for Type 2 Diabetes: Early Communication - Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas
3/15/2013
DOHMH Alert #5: Invasive Meningococcal Disease in Men Who Have Sex with Men, Four New Cases Reported in 2013, Expanded Vaccine Recommendations
3/13/2013
Azithromycin (Zithromax or Zmax): Drug Safety Communication - Risk of Potentially Fatal Heart Rhythms
2/28/2013
Omontys peginesatide Injection by Affymax and Takeda Recall
2/20/2013
Vistide (Cidofovir Injection) by Gilead: Recall - Presence Of Particulate Matter
2/4/2013
Register To Receive City Health Information Bulletins
1/30/2013
Lactated Ringers and 5 Percent Dextrose Injection, USP, 1000 ML, Flexible Containers: Recall - Due to Non-Sterility
1/30/2013
Recommendations for Drug Allocation, Tuberculosis Prevention and Patient Care During Isoniazid Shortages
1/30/2013
Summary of CDC Recommendations for Influenza Antiviral Medications
1/25/2013
Samsca (tolvaptan): Drug Warning - Potential Risk of Liver Injury
1/22/2013
Ferrous Sulfate Tablets, 325 mg Labeled as Rugby Natural Iron Supplement: Recall - Bottle May Contain Meclizine HCl 25 mg Tablets
1/16/2013
Executive Order Allows Pharmacists in New York State to Vaccinate Children Ages 6 Months to 18 Years
1/16/2013
NYSDOH Authorizes Use of Influenza Vaccines Containing Thimerosal
1/11/2013
Mobius brand Mitosol (mitomycin for solution) Kit for Ophthalmic Use: Recall-May Not be Sterile
1/10/2013
DOHMH 2013 Advisory #2 - NYC Influenza Update
1/10/2013
DOHMH 2013 Alert #1 - Neonatal Herpes
1/2/2013
Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg: Recall - Potential for Oversized Tablets
12/20/2012
Incivek (telaprevir) In Combination with Drugs Peginterferon Alfa and Ribavirin (Incivek combination treatment): Drug Safety Communication - Serious Skin Reactions
12/18/2012
DOHMH 2012 Advisory # 38- Influenza Advisory
12/18/2012
Xyrem (sodium oxybate): Drug Safety Communication - Warning Against Use With Alcohol or Drugs Causing Respiratory Depression
12/17/2012
Carboplatin Injection by Hospira: Recall - Visible Particulate Matter Identified
12/7/2012
Qualitest Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg: Recall - Potential for Oversized Tablets
12/5/2012
Ondansetron (Zofran) 32 mg, Single Intravenous (IV) Dose: Updated Safety Communication – Product Removal due to Potential For Serious Cardiac Risk
11/20/2012
Manufacturer Initiates Nationwide Voluntary, Patient Level Recall for One Lot of Pradaxa®
11/16/2012
CDC Advisory - Voluntary Recall of All Ameridose Medical Products
11/16/2012
Pradaxa (dabigatran etexilate mesylate): Drug Safety Communication - Safety Review of Post-Market Reports of Serious Bleeding Events
10/22/2012
DOHMH Alert # 30 - UPDATE: Invasive Meningococcal Disease in Men Who Have Sex with Men
10/19/2012
FDA Statement on Fungal Meningitis Outbreak: Additional Patient Notification Advised
10/19/2012
Hospira Lactated Ringer’s And 5% Dextrose Injection, 1000 Ml, Flexible Containers: Recall - Mold Contamination
10/11/2012
Update: Multistate Outbreak of Meningitis and Stroke Associated with Potentially Contaminated Steroid Medication
10/10/2012
New York State Department of Health Statement on Multistate Fungal Meningitis Outbreak
10/9/2012
2012 ALERT # 28 UPDATE: Meningococcal Vaccine Recommendations for HIV-infected Men Who Have Sex with Men
10/3/2012
DOHMH Alert #27: Invasive Meningococcal Disease in Men Who Have Sex with Men
9/24/2012
Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg (Watson Laboratories): Recall - Potential for Oversized and Superpotent Tablets
9/19/2012
Mirapex (pramipexole): Drug Safety Communication - Ongoing Safety Review, Possible Risk of Heart Failure
9/13/2012
Qualitest Issues Voluntary, Nationwide Recall for One Lot of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg Due to the Potential for Oversized Tablets
9/5/2012
Nimodipine: Recall - Crystallization of Fill Material
9/5/2012
Revatio (sildenafil): Drug Safety Communication - Recommendation Against Use in Children
8/14/2012
Pesticide Spraying Notification
8/7/2012
First Human Case of West Nile Viral Disease in NYC
8/7/2012
Increase in Influenza A H3N2v Virus Infections in Three U.S. States
7/25/2012
Drug Safety Communication - Seizure Risk for Multiple Sclerosis Patients
7/18/2012
22012 DOHMH Advisory #14: Tick-borne Disease Advisory
7/17/2012
2012 DOHMH Advisory #8: West Nile Virus
7/17/2012
Testing and Reporting Guidelines for Cases of Viral Encephalitis and Meningitis West Nile
7/13/2012
iFlora Kids Multi-Probiotic and iFlora 4-Kids Powder Dietary Supplements: Recall - Possible Salmonella Contamination
7/13/2012
Ondansetron (Zofran) IV: Drug Safety Communication - QT Prolongation
7/13/2012
Vecuronium Bromide For Injection Preservative Free (Bedford Laboratories): Recall - Particulate Matter
7/2/2012
Use of Azithromycin to Treat STDs
6/25/2012
HIV/AIDS Resources Available for Your Patients
6/21/2012
Podcasts on Medication Management
6/11/2012
Introvale (levonorgestrel and ethinyl estradiol) Tablets: Recall - Packaging Flaw
5/31/2012
Teva’s Adderall 30-mg Tablets: Counterfeit Product — Contains Wrong Active Ingredients
5/25/2012
Reimbursement for Smoking Cessation: New Tools From the NYS Smokers’ Quitline
5/15/2012
Falls In Older Adults: Statistics and Prevention
Amikacin Sulfate Injection USP 500 mg/2 mL (250 mg/mL) and 1 Gram/4 mL (250 mg/mL) Vials by Teva: Recall - Glass Particulate Matter